Novocure Earnings Estimate

NVCR Stock  USD 16.45  0.27  1.61%   
By analyzing Novocure's earnings estimates, investors can diagnose different trends across Novocure's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Novocure is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Yuan Drop
 
Covid
Novocure is projected to generate -0.39 in earnings per share on the 30th of June 2025. Novocure earnings estimates show analyst consensus about projected Novocure EPS (Earning Per Share). It derives the highest and the lowest estimates based on Novocure's historical volatility. Many public companies, such as Novocure, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Novocure's earnings estimates, investors can diagnose different trends across Novocure's analyst sentiment over time as well as compare current estimates against different timeframes. As of 06/06/2025, Gross Profit is likely to drop to about 246.6 M. In addition to that, Pretax Profit Margin is likely to drop to -0.23Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novocure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in Novocure Stock, please use our How to Invest in Novocure guide.

Novocure Earnings per Share Projection vs Actual

About Novocure Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Novocure earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Novocure estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Novocure fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-1.2 B-1.1 B
Retained Earnings Total Equity-700.6 M-735.6 M
Earnings Yield(0.05)(0.06)
Price Earnings Ratio(19.06)(20.01)
Price Earnings To Growth Ratio 0.95  0.91 

Additional Tools for Novocure Stock Analysis

When running Novocure's price analysis, check to measure Novocure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novocure is operating at the current time. Most of Novocure's value examination focuses on studying past and present price action to predict the probability of Novocure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novocure's price. Additionally, you may evaluate how the addition of Novocure to your portfolios can decrease your overall portfolio volatility.